The global cri-du-chat syndrome treatment market was valued at $1,332.46 thousand in 2021, and is estimated to reach $1,918.21 thousand by 2031, growing at a CAGR of 3.7% from 2022 to 2031.
Cri du chat syndrome, also known as 5p- syndrome and cat cry syndrome, is a rare genetic disorder brought on by the deletion of genetic material from the short arm of chromosome 5 (the p arm), which is responsible for the illness. This unusual chromosomal loss has an unidentified cause. A high-pitched cry, a small head, and a flattened nasal bridge are the hallmarks of a baby with cri du chat syndrome.
It is estimated that one in every 50,000 or so infants has this disease. This estimate is decreasing. It may be as low as one in 25,000 with more sophisticated and regular genetic testing and many milder cases being detected. Thus, high prevalence of cri-du-chat syndrome along with increase in diagnosis for genetic diseases drives the market growth.
This syndrome has no particular pharmacological treatments available. To assist the child reach their full potential, children born with this genetic disorder will probably need ongoing care from a team made up of the parents, therapists, and medical and educational experts. They can achieve their full potential and lead fulfilling lives with early and consistent physical therapy, occupational and speech therapy. In addition, rise in awareness and advantages about physiotherapy, occupational & speech therapy is the major factor driving the market. The increase in prevalence of disease and out-of-pocket expenditure has led to a significant rise in healthcare cost. These factors propel the market growth.
However, high cost associated with therapy treatments are expected to hinder the growth of the market. Conversely, growth opportunities in emerging market to suffice the consumer demands is expected to provide a great opportunity for the investors to invest in the market.
The cri-du-chat syndrome treatment market is segmented on the basis of treatment, end user, and region. On the basis of product, the market is categorized into physiotherapy, speech therapy and occupation therapy. On the basis of end user, it is segmented into hospitals & specialty clinics and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
The major players profiled in the report are Hoppers Physio, Jeevam Therapy, Physiocomestoyou, EURO-THERAPIES, Institute for Child Development, Blossoms Physiotherapy, Pediatric Advanced Therapy, Chatham Speech and Myo, Movement Masters Physical Therapy, and Rio Children's Hospital.
Cri du chat syndrome, also known as 5p- syndrome and cat cry syndrome, is a rare genetic disorder brought on by the deletion of genetic material from the short arm of chromosome 5 (the p arm), which is responsible for the illness. This unusual chromosomal loss has an unidentified cause. A high-pitched cry, a small head, and a flattened nasal bridge are the hallmarks of a baby with cri du chat syndrome.
It is estimated that one in every 50,000 or so infants has this disease. This estimate is decreasing. It may be as low as one in 25,000 with more sophisticated and regular genetic testing and many milder cases being detected. Thus, high prevalence of cri-du-chat syndrome along with increase in diagnosis for genetic diseases drives the market growth.
This syndrome has no particular pharmacological treatments available. To assist the child reach their full potential, children born with this genetic disorder will probably need ongoing care from a team made up of the parents, therapists, and medical and educational experts. They can achieve their full potential and lead fulfilling lives with early and consistent physical therapy, occupational and speech therapy. In addition, rise in awareness and advantages about physiotherapy, occupational & speech therapy is the major factor driving the market. The increase in prevalence of disease and out-of-pocket expenditure has led to a significant rise in healthcare cost. These factors propel the market growth.
However, high cost associated with therapy treatments are expected to hinder the growth of the market. Conversely, growth opportunities in emerging market to suffice the consumer demands is expected to provide a great opportunity for the investors to invest in the market.
The cri-du-chat syndrome treatment market is segmented on the basis of treatment, end user, and region. On the basis of product, the market is categorized into physiotherapy, speech therapy and occupation therapy. On the basis of end user, it is segmented into hospitals & specialty clinics and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
The major players profiled in the report are Hoppers Physio, Jeevam Therapy, Physiocomestoyou, EURO-THERAPIES, Institute for Child Development, Blossoms Physiotherapy, Pediatric Advanced Therapy, Chatham Speech and Myo, Movement Masters Physical Therapy, and Rio Children's Hospital.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cri-du-chat syndrome treatment market analysis from 2021 to 2031 to identify the prevailing cri-du-chat syndrome treatment market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cri-du-chat syndrome treatment market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cri-du-chat syndrome treatment market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Treatment
- Physiotherapy
- Speech therapy
- Occupational therapy
By End User
- Hospitals and specialty clinics
- Others
By Region
- North America
- U. S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Hoppers Physio
- Chatham Speech and Myo
- Movement Masters Physical Therapy
- Rio Children's Hospital
- Blossoms Physiotherapy
- Institute for Child Development
- Pediatric Advanced Therapy
- EURO-THERAPIES
- Physiocomestoyou
- Jeevam Therapy
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY TREATMENT
4.1 Overview
4.1.1 Market size and forecast
4.2 Physiotherapy
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Speech therapy
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4 Occupational therapy
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
CHAPTER 5: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY END USER
5.1 Overview
5.1.1 Market size and forecast
5.2 Hospitals and specialty clinics
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Others
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: CRI-DU-CHAT SYNDROME TREATMENT MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Treatment
6.2.3 North America Market size and forecast, by End User
6.2.4 North America Market size and forecast, by country
6.2.4.1 U. S.
6.2.4.1.1 Key market trends, growth factors and opportunities
6.2.4.1.2 Market size and forecast, by Treatment
6.2.4.1.3 Market size and forecast, by End User
6.2.4.2 Canada
6.2.4.2.1 Key market trends, growth factors and opportunities
6.2.4.2.2 Market size and forecast, by Treatment
6.2.4.2.3 Market size and forecast, by End User
6.2.4.3 Mexico
6.2.4.3.1 Key market trends, growth factors and opportunities
6.2.4.3.2 Market size and forecast, by Treatment
6.2.4.3.3 Market size and forecast, by End User
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Treatment
6.3.3 Europe Market size and forecast, by End User
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Key market trends, growth factors and opportunities
6.3.4.1.2 Market size and forecast, by Treatment
6.3.4.1.3 Market size and forecast, by End User
6.3.4.2 France
6.3.4.2.1 Key market trends, growth factors and opportunities
6.3.4.2.2 Market size and forecast, by Treatment
6.3.4.2.3 Market size and forecast, by End User
6.3.4.3 UK
6.3.4.3.1 Key market trends, growth factors and opportunities
6.3.4.3.2 Market size and forecast, by Treatment
6.3.4.3.3 Market size and forecast, by End User
6.3.4.4 Italy
6.3.4.4.1 Key market trends, growth factors and opportunities
6.3.4.4.2 Market size and forecast, by Treatment
6.3.4.4.3 Market size and forecast, by End User
6.3.4.5 Spain
6.3.4.5.1 Key market trends, growth factors and opportunities
6.3.4.5.2 Market size and forecast, by Treatment
6.3.4.5.3 Market size and forecast, by End User
6.3.4.6 Rest of Europe
6.3.4.6.1 Key market trends, growth factors and opportunities
6.3.4.6.2 Market size and forecast, by Treatment
6.3.4.6.3 Market size and forecast, by End User
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Treatment
6.4.3 Asia-Pacific Market size and forecast, by End User
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Key market trends, growth factors and opportunities
6.4.4.1.2 Market size and forecast, by Treatment
6.4.4.1.3 Market size and forecast, by End User
6.4.4.2 China
6.4.4.2.1 Key market trends, growth factors and opportunities
6.4.4.2.2 Market size and forecast, by Treatment
6.4.4.2.3 Market size and forecast, by End User
6.4.4.3 India
6.4.4.3.1 Key market trends, growth factors and opportunities
6.4.4.3.2 Market size and forecast, by Treatment
6.4.4.3.3 Market size and forecast, by End User
6.4.4.4 Australia
6.4.4.4.1 Key market trends, growth factors and opportunities
6.4.4.4.2 Market size and forecast, by Treatment
6.4.4.4.3 Market size and forecast, by End User
6.4.4.5 South Korea
6.4.4.5.1 Key market trends, growth factors and opportunities
6.4.4.5.2 Market size and forecast, by Treatment
6.4.4.5.3 Market size and forecast, by End User
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Key market trends, growth factors and opportunities
6.4.4.6.2 Market size and forecast, by Treatment
6.4.4.6.3 Market size and forecast, by End User
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Treatment
6.5.3 LAMEA Market size and forecast, by End User
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Key market trends, growth factors and opportunities
6.5.4.1.2 Market size and forecast, by Treatment
6.5.4.1.3 Market size and forecast, by End User
6.5.4.2 Saudi Arabia
6.5.4.2.1 Key market trends, growth factors and opportunities
6.5.4.2.2 Market size and forecast, by Treatment
6.5.4.2.3 Market size and forecast, by End User
6.5.4.3 South Africa
6.5.4.3.1 Key market trends, growth factors and opportunities
6.5.4.3.2 Market size and forecast, by Treatment
6.5.4.3.3 Market size and forecast, by End User
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Key market trends, growth factors and opportunities
6.5.4.4.2 Market size and forecast, by Treatment
6.5.4.4.3 Market size and forecast, by End User
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Players
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Hoppers Physio
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Jeevam Therapy
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Physiocomestoyou
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 EURO-THERAPIES
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Institute for Child Development
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Blossoms Physiotherapy
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Pediatric Advanced Therapy
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Chatham Speech and Myo
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Movement Masters Physical Therapy
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Rio Children's Hospital
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
Executive Summary
According to this report, titled, 'Cri-du-chat Syndrome Treatment Market,' the cri-du-chat syndrome treatment market was valued at $1.3 million in 2021, and is estimated to reach $1.9 million by 2031, growing at a CAGR of 3.7% from 2022 to 2031.When a portion of chromosome number 5 is missing, a series of symptoms known as'cri du chat syndrome' develop. The name of the syndrome is derived from the baby's high-pitched, feline-like cry. The majority of occurrences are thought to happen when the egg or sperm are developing. There are a few instances where a parent transmits their child a different, rearranged form of the chromosome.
Cri du Chat syndrome is typically not inherited within families and this deletion takes place extremely early in an embryo's development. The clinical examination, the patient's symptoms, and the results of genetic testing are used to make the diagnosis.
There is no pharmacological treatment for this disease. Thus, there is significant rise in awareness about physiotherapy for the treatment of the cri-du-chat syndrome is the major factor driving the market growth. In addition, increase in healthcare expenditure is the upcoming cri-du-chat syndrome treatment market trends in emerging economies also propels the market growth.
However high cost associated with treatment of physiotherapy is expected to hinder the market growth. Conversely, rising purchasing power, emerging economies in Asia-Pacific and LAMEA have one of the highest growth potentials for the cri-du-chat syndrome treatment market.
The cri-du-chat syndrome treatment market analysis is segmented by treatment, end user and region. On the basis of treatment, the market is segmented into physiotherapy, occupation therapy and speech therapy. The physiotherapy segment dominated the cri-du-chat syndrome treatment market size in 2021, and also expected to witness highest CAGR during the forecast period, owing to rise in awareness and advantages about physiotherapy.
On the basis of end user, the market is divided into hospitals & specialty clinics and others. The hospitals & specialty clinics segment dominated the cri-du-chat syndrome treatment market size in 2021, owing to hospitals & specialized centers provides high specialized treatment for such patients. The others segment is expected to witness highest CAGR during the forecast period owing to rise in demand for the home care private services and increase in the number of medical institutes that provide such treatments.
North America accounted for a majority of the global cri-du-chat syndrome treatment market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to technological advancements in physiotherapy techniques, rise in awareness about occupational & speech treatment for cri-du-chat syndrome, presence of key and robust hospital infrastructure in the region. However, Asia-Pacific is anticipated to witness notable growth in the cri-du-chat syndrome treatment market forecast, owing to rise in cri-du-chat syndrome, development of healthcare infrastructure and increase in investments projects in the region.
Key findings of the study
- On the basis of treatment, the physiotherapy segment was the highest contributor to the cri-du-chat syndrome treatment market share in 2021.
- On the basis of end user, the hospitals and specialty clinics segment was highest contributor in 2021, and is expected to continue this trend during the forecast period in the cri-du-chat syndrome treatment industry.
- Region wise, North America garnered the largest revenue share in cri-du-chat syndrome treatment industry in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Hoppers Physio
- Chatham Speech and Myo
- Movement Masters Physical Therapy
- Rio Children's Hospital
- Blossoms Physiotherapy
- Institute for Child Development
- Pediatric Advanced Therapy
- Euro-Therapies
- Physiocomestoyou
- Jeevam Therapy
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 148 |
| Published | October 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 1332.46 thousand |
| Forecasted Market Value ( USD | $ 1918.21 thousand |
| Compound Annual Growth Rate | 3.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
